Trial intelligence / Profile preview

Cinacalcet vs conventional therapy on mineral metabolism and vascular stiffness in CKD stage 5

2013-002270-52Phase 4Active

Sponsor
Hospital Universitari de Girona Dr. Josep Trueta
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of cinacalcet in chronic kidney disease (CKD), secondary hyperparathyroidism (SHPT), chronic kidney disease-mineral and bone disorder (CKD-MBD) and 1 more (2 arms), sponsored by Hospital Universitari de Girona Dr. Josep Trueta. Started Nov 2013; status: active.

02

Drugs

cinacalcet
03

Conditions

chronic kidney disease (CKD)secondary hyperparathyroidism (SHPT)chronic kidney disease-mineral and bone disorder (CKD-MBD)arterial calcification

Beyond the preview

Go deeper on 2013-002270-52.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002270-52.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call